Literaturverzeichnis

1. R. Dengler, S. Zierz, F. Jerusalem: Amyotrophe Lateralsklerose, Georg Thieme Verlag Stuttgart; 1994

2. J.M. Charcot : De la sclérose latérale amyotrophique ; Prog Med 2 ; 325-327 ; 1874

3. L.M. Nelson, V. McGuire, W.T. Longstreth, C. Matkin: Population-based case-control study of amyotrophic lateral sclerosis in Western Washington State. Cigarette smoking and alcohol consumption; Am J Epidemiol 151(2); 156-163; 2000

4. H. Mitsumoto, M.R. Hanson, D.A. Chad: Amyotrophic lateral sclerosis: recent advantages in pathogenesis and therapeutic approaches; Arch Neurol 45;189-202; 1988

5. L. P. Rowland: Motor neuron disease and amyotrophic lateral sclerosis: research progress; TINS 10(10); 393-398; 1987

6 . R.G. Smith, L. Siklos, M.E. Alexianu, J.I. Engelhardt, D.R. Mosier, L. Colom, A. Habib Mohamed, S.H. Appel: Autoimmunity and ALS; Neurology 47(4); 40-45; 1996

7 . M.R. Ciriolo, A. De Martino, E. Lafavia, L. Rossi, M.T. Carri, G. Rotilio: Cu,Zn-superoxide dismutase dependent apoptosis induced by nitric oxide in neuronal cells; J Biol Chem 275(7); 5065-5072; 2000

8. L.J. Martin: Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death; J Neuropathol Exp Neurol 58(5); 459-471; 1999

9. P.S. Spencer, A.C. Ludolph et al: Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin; Science 237(4814); 517-522; 1987

10. R. Bachus, A. Claus, T. Meyer, M. Riepe, A.C. Ludolph: Molekularbiologische Befunde bei der amyotrophen Lateralsklerose; Der Nervenarzt 68 ; 785-791; 1997

11. A.C. Ludolph, T. Meyer, M.W. Riepe: The role of excitotoxicity in ALS-what is the evidence ? J Neurol 247; 7-16; 2000

12 . M. Dragunow, G.A. MacGibbon, P. Lawlor, N. Butterworth, B. Connor, C. Henderson, M. Walton, A. Woodgate, P. Hughes, R.L. Faull: Apoptosis, neurotrophic factors and neurodegeneration; Rev Neurosci 8(3-4); 223-265; 1997

13 . B. Connor, M. Dragunow: The role of neuronal growth factors in neurodegenerative disorders of the human brain; Brain Res Brain Res Rev 27(1); 1-39; 1998

14 . J.D. Rothstein, L.J. Martin, R.W. Kuncl: Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis; N Eng J Med 326(22); 1464-1468; 1992

[Seite 89↓]

15 . R.R. Roos, T. Siddique, J.A. Trainer: Summary of SOD and free radicals in ALS and neurodegeneration conference; Neurology 45; 1779-1780; 1995

16 . J.D. Rothstein, M. Van Kammen, A.I. Levey, L.J. Martin, R.W. Kuncl: Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis; Ann Neurol 38(1); 73-84; 1995

17 . M. Aoki, C.L. Lin, J.D. Rothstein, B.A. Geller, B.A. Hosler, T.L Munsat, H.R. Horvitz, R.H. Brown: Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis; Ann Neurol 43(5); 645-653; 1998

18 . T. Meyer, A. Speer, B. Meyer, W. Sitte, G. Küther, A.C. Ludolph: The glial glutamate transporter DNA in patients with amyotrophic lateral sclerosis; Ann Neurol 40; 456-459; 1996

19 . T. Meyer, A. Fromm, C. Munch, B. Schwalenstocker, A.E. Fray, P.G. Ince, S. Stamm, G. Gron, A.C. Ludolph, P.J. Shaw: The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals; J Neurol Sci 170(1); 45-50; 1999

20.M. Jackson, G. Steers, P.N. Leigh, K.E. Morrison; Polymorphisms in the glutamate transporter gene EAAT2 in european ALS patients; J Neurol 246(12); 1140-1144; 1999

21 . T.P. Obrenovitch, J. Urenjak, E. Zilkha, T.M. Jay: Excitotoxicity in neurological disorders – the glutamate paradox; Int J Dev Neurosci 18(2-3); 281-287; 2000

22 . A.C. Ludolph, T. Meyer, M.W. Riepe: Antiglutamate therapy of ALS- wich is the next step? J Neural Transm Suppl 55; 79-95; 1999

23. G.C. Tsai, B. Stauch-Slusher, L. Sim, J.C. Hedreen, J.D: Rothstein, R. Kuncl, J.T. Coyle: Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis; Brain Res 556(1); 151-156; 1991

24. C. Krieger, R.A. Lanius, S.L. Pelech, C.A. Shaw: Amyotrophic lateral sclerosis: the involvement of intracellular Ca2+ and protein kinase C; Trends Pharmacol Sci 17(3); 114-120; 1996

25. J. B. Schulz, J. Lindenau, J. Seyfried, J Dichgans: Glutathione, oxidative stress and neurodegeneration; Eur. J. Biochem 267 (16); 4904-4911; 2000

26 . F. Facchinetti, V.L. Dawson, T.M. Dawson: Free radicals as mediators of neuronal injury; Cell Mol Neurobiol 18(6); 667-682; 1998

27. D. J. Waggoner, T. B. Bartnikas, J.D. Gitlin: The role of copper in neurodegenerative disease; Neurobiol Dis 6 (4); 221-230; 1999

28 . M.E. Gurney, H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, J. Caliendo, A. Hentati, Y.W. Kwon, H.-X. Deng, W. Chen, P. Zhai, R.L. Sufit, T. Siddique: Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation; Science 264;1772-1775; 1994

[Seite 90↓]

29 . M. Bogdanov, R.H. Brown, W. Matson, R. Smart, D. Hayden, H. O´Donnell, M.F. Beal, M. Cudkowicz: Increased oxidative damage to DNA in ALS patients; Free Radical Biology and Medicine 29(7); 652-658; 2000

30 . R. G. Smith, Y.K. Henry, M.P. Mattson, S.H. Appel: Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis; Ann Neurol 44(4); 696-699; 1998

31 . W.A. Pedersen, W. Fu, J.N. Keller, W.R. Markesbery, S. Appel, R.G. Smith, E. Kasarskis, M.P. Mattson: Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients; Ann Neurol 44(5); 819-824; 1998

32 . H. Lovschall, M. Kassem, L. Mosekilde : Apoptosis: molecular aspects; Nord Med 112(8); 271-275; 1997

33 . L.J. Martin, A.C. Price, A. Kaiser, A.Y. Shaikh, Z. Liu: Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review); Int J Mol Med 5(1); 3-13; 2000

34 . B.P. He, M.J. Strong: Motor neuronal death in sporadic amyotrophic lateral sclerosis is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits; Neuropathology and applied Neurobiology 26(2); 150-160; 1999

35 . R.J. Reiter, J Cabrera, R.M. Sainz, J.C. Mayo, L.C. Manchester, D.X. Tan: Melatonin as a pharmagological argent against neuronal loss in experimental models of Huntigton´s disease, Alzheimer´s disease and parkinsonism; Ann N Y Sci 890; 471-485; 1999

36 . D. Liu, R. Yang, X. Yan, D.J. McAdoo: Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: electrophysiological, histological and neurochemical results; J Neurochem 62(1); 37-44; 1994

37 . T. Siddique, D.A. Figlewicz, M.A. Pericak-Vance, J.L. Haines, G. Rouleau, A.J. Jeffers, P. Sapp, W.-Y. Hung, J. Bebout, J. McKena-Yasek, G. Deng, H.R. Horvitz, J.F. Gusella, R.H. Brown, A.D. Roses et al.: Linkage of a gene causing amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic locus heterogenity; N Eng J Med 324; 1381-1384; 1991

38 . D. Liu, J. Wen, J. Liu, L. Li: The roles of free radicals in amyotrophic lateral sclerosis. Reactive oxygen species and elevated oxidation of protein, DNA and membrane phospholipids; Faseb J 13; 2318-2328; 1999

39 . M. Jackson, A. Al-Chalabi, Z.E. Enayat, B. Chioza, P. N. Leigh, K.E. Morrison: Copper/Zink superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation; Ann Neurol 42(5); 803-807; 1997

40 . H.X. Deng, A. Hentati, J.A. Tainer, Z. Iqbal, A. Cayabyab, W.Y. Hung, E.D. Getzoff, P. Hu, B. Hertzfeld, R.P. Roos et al: Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase; Science 261(5124); 1047-1051; 1993

[Seite 91↓]

41 . A.C. Bowling, J.B. Schulz, R.H. Brown, M.F. Beal: Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis; J Neurochem 61(6); 2322-2325; 1993

42 .P.M. Andersen, P. Nilsson, L. Forsgren, S.L. Marklund: Cu/Zn-superoxide dismutase, extracellular glutathione peroxidase in blood from individuals homozygous for Asp90Ala Cu/Zn-superoxide dismutase mutation; J Neurochem 70; 715-720 ; 1998

43 . R. Moumen, A. Nouvelot, D. Duval, B. Lechevalier, F. Viader: Plasma superoxide dismutase and glutathione peroxidase activity in sporadic amyotrophic lateral sclerosis; J Neurol Sci 151(1); 35-39; 1997

44 . S. Przedborski, D.M. Donaldson, P.L Murphy, O. Hirsch, D. Lange, A.B. Naini, D. McKenna-Yasek, R.H. Brown: Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis; Neurodegeneration 5(1); 57-64; 1996

45 . K. Fujita, M. Yamauchi, K. Shibayama, M. Ando, M. Honda, Y. Nagata: Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis; J Neurosci Res 45(3); 276-281; 1996

46 . D. Bonnefort-Rousselot, L. Lacomblez, M.-C. Jaudon, S. Lepage et al.: Blood oxidative stress in amyotrophic lateral sclerosis ; J Neurol Sci 178(1); 57-62; 2000

47 . G.F. van Landeghem, P. Tabatabaie, G. Beckmann, L. Beckmann, P.M. Andersen: Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease; Eur J Neurol 6(6); 639-644; 1999

48 . G. McEachern, S. Kassovska-Bratinova, S. Raha, M.A. Tarnopolsky, J. Turnbull, J. Bourgeois, B. Robison: Manganese superoxide dismutase levels are elevated in a proportion of amyotrophic lateral sclerosis patient cell lines; Biochemical and Biophysical Research Comm 273; 2000

49. G.L. Squadrito, W.A. Pryor: Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite and carbon dioxide; Free Radic Biol Med 25(4-5); 392-403; 1998

50 . F. Torreilles, S. Salman-Tabcheh, M.-C. Guérin, J. Torreilles: Neurodegenerative disorders: the role of peroxynitrite; Brain Research Reviews 30; 153-163; 1999

51 . A.G. Estevez, N. Spear, S.M. Manuel, L. Barbeito, R Radi, J.S. Beckman: Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture; Prog Brain Res 118; 269-280; 1998

52 . A. H. Cross, P.T. Manning, M.K. Stern, T.P. Misko: Evidence for the production of peroxynitrite in inflammatory CNS demyelination; J Neuroimmunol 80(1-2); 121-130; 1997

[Seite 92↓]

53. L.I. Bruijn, M.F. Beal, M.W. Becher, J.B. Schulz, P.C. Wong, D.L. Price, D. W. Cleveland: Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis-like diseases implicate tyrosine nitration as an abberant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant; Proc Natl Acad Sci 94(14); 7606-7611; 1997

54 . J.P. Crow, J.B. Sampson, Y. Zhuang, J.A. Thompson, J.S. Beckman: Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite; J Neurochem 69(5 ); 1936-1944; 1997

55 . K. Abe, L.H. Pan, M. Watanabe, H. Konno, T. Kato, Y. Itoyama: Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis; Neurol Res 19(2); 124-128; 1997

56 . K. Abe, L.H. Pan, M. Watanabe, T. Kato, Y. Itoyama: Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis; Neurosci Lett 199(2); 152-154; 1995

57 . H. Tohgi, T. Abe, K. Yamazaki, T. Murata, E. Ishizaki, C. Isobe: Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis; Ann Neurol 46(1); 129-131; 1999

58 . G.F. Weber: Final common pathways in neurodegenerative diseases: regulatory role of the glutathione cycle; Neurosci Biobehav Rev 23(8); 1079-1086; 1999

59 . J.S. Bains, C.A. Shaw: Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death; Brain Res Brain Res Rev 25(3); 335-358; 1997

60 . M.E. Cudkowicz, P.M. Sexton, T. Ellis, D.L. Hayden, P.R. Gwilt, J. Whalen, R.H. Brown: The pharmakokinetics and pharmaco-dynamics of procysteine in amyotrophic lateral sclerosis; Neurology 52; 1492-1494; 1999

61 . P. Riederer, E. Sofic, W.D. Rausch, B. Schmidt, G.P. Reynolds, K. Jellinger, M.B. Youdim: Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains; J Neurochem 52; 515-520; 1989

62 . R.A. Lanius, C. Krieger, R. Wagey, C.A. Shaw: Increased 35s glutathione binding sites in spinal cords from patients with sporadic amyotrophic lateral sclerosis; Neurosci Lett 163(1); 89-92; 1993

63 . A. Chio, A. Cucatto, A.A. Terreni, D. Schiffer: Reduced glutathione in amyotrophic lateral sclerosis: an open, crossover, randomized trial; Ital J Neurol Sci 19(6); 363-366; 1998

64 . S. Chada, M.M. Le Beau, L. Casey, P.E. Newburger: Isolation and chromosomal location of the human glutathione peroxidase gene; Genomics 6; 268-271; 1990

65 . S. Apostolski, Z. Marinkovic, A. Nikolic, D. Blagojevic, M.B. Spasic, A.M. Michelson: Glutathione peroxidase in amyotrophic lateral sclerosis: the effects of selenium supplementation; J Environ Pathol Toxicol Oncol 17(3-4); 325-329; 1998

66 . S. Przedborski, D. Donaldson, M. Jakowec, S.J. Kish, M. Guttmann, G. Rosoklija, A.P. Hays: Brain superoxide dismutase, catalase and glutathione peroxidase activities in ALS; Ann Neurol 9; 158-165; 1996

[Seite 93↓]

67 . P.G. Ince, P.J. Shaw, J.M. Candy et al.: Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease; Neurosci Lett 182; 87-90; 1994

68 . M.J. Bullido, F. Valdivieso: Apolipoprotein E gene promoter polymorphisms in Alzheimer´s disease; Microsc Res Tech 50(4); 261-267; 2000

69 . L. Lannfeldt, C. Nordstedt: Genetics of Alzheimer´s Disease – routes to the pathophysiology; J Neural Transm Suppl 59; 155-161; 2000

70 . A. Al-Chalabi, Z.E. Enayat, M.C. Bakker, P.C. Sham, D.M. Ball, C.E. Shaw, C. M. Lloyd, J.F. Powell, P. N. Leigh: Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease; Lancet 347(8995); 159-160; 1996

71 . C. Hayward, S. Colville, R.J. Swingler, D.J. Brock: Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis ; Neurology 52(9); 1899-1901; 1999

72 . Z. Xu, L.C. Cork, J.W. Griffin, D.W. Cleveland: Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease; Cell 73; 23-33; 1993

73 . J.F. Collard, F. Cote, J.P. Julien : Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis; Nature 375(6526); 61-64; 1995

74 . D. Janet, B.S. Vechio, L.I. Bruijn, Z. Xu, R.H. Brown, D.W. Cleveland: Sequence variants in human neurofilament proteins: absence of linkage to familial ALS; Ann Neurol 40(4); 603-610; 1996

75. L.Stryer: Biochemie; Spektrum Akademischer Verlag; Heidelberg, Berlin, New York; 1991

76 . S.C. Harry: Slipped structures in DNA triplet repeat sequences: entropic contributions to genetic instabilities; Biochemistry 36(11); 3047-3049; 1997

77 . C. Neri, V. Albanése, A.-S. Lebre, S. Holbert, C. Saada, L. Bougueleret, S. Meier-Ewert, I. Le Gall, P. Millasseau et al: Survey of CAG/CTG repeats in human cDNAs representing new genes: candidates for neurological disorders; Hum Mol Genet 5(7); 1001-1009; 1996

78 . A. Abel, A. Danek, G.D. Borasio, Th.N. Witt: X-chromosomal bulbospinal neuronopathy ( Kennedy-Syndrom ): a disorder with repetitive triplet sequences. Case studies, differantial diagnosis and molecular genetic aspects; Nervenarzt 67; 1011-1019; 1996

79 . W.S. Watkins, M. Bamshad, L.B. Jorde: Population genetics of trinukleotide repeat polymorphism; Hum Mol Genet 4 (9); 1485-1491; 1995

80. S. Igarashi, Y. Tanno, O. Onodera, M. Yamazaki, S. Sato, A. Ishikawa, N. Miyatani, M. Nagashima et al.: Strong correlations between the number of CAG repeats in androgen rezeptor genes and the clinical onset of features of spinal and bulbar muscular atrophy; Neurology 42; 2300-2302; 1992

[Seite 94↓]

81 . A.R. La Spada, H.L. Paulsen, K.H. Fischbeck: Trinucleotide repeat expansion in neurological disease; Ann Neurol 36; 814-822; 1994

82 . Q. Shen, P.L. Townes, C. Padden, P.E. Newburger: An in-frame trinucleotide repeat in the coding region of the human gluathione peroxidase ( GPX1) gene: in vivo polymorphism and in vitro instability; Genomics 23; 292-294; 1994

83 . A.E.H. Emery: Population frequencies of neuromuscular diseaes II. Amyotrophic lateral sclerosis (motor neurone disease); Neuromusc Disord 1; 323; 1991

84 . J.F. Kurtzke: Risk factors in amyotrophic lateral sclerosis. In L.P. Rowland : Advances in Neurology, Vol. 56: Amyotrophic lateral sclerosis and other motor neuron diseases; Raven Press; New York; 245; 1991

85 . R.D. Currier, D.E. Conwill: Influenza and physikal activities as possible risk factors for amyotrophic lateral sclerosis; a study of twins. In F.C. Rose, F.H. Norris; Amyotrophic lateral sclerosis; Smith Gordon, Nishimura; 23; 1990

86 . R.A. Dengler, S. Konstanzer, S. Hesse, M. Schubert, W. Wolf: Collateral nerve sprouting and twitch forces of single motor neuron units in conditions with partial denervation in man; Neurosci Lett 97; 118-122; 1989

87 . L.P. Rowland, R. Defendini, W.H. Sherman, A. Hirano, M.R. Olarte, N. Latov, R.E. Lovelace, K. Inoue, E.F. Osserman: Macroglobulinemia with peripheral neuropathy simulating motor neuron disease; Ann Neurol 11; 532; 1981

88. J.M. Matés, F. Sanchez-Jimenéz: Antioxidant enzymes and their implications in pathophysiologic processes; Frontieres in Bioscience 4; 339-345; 1999

89 . D. Pearson, J. Suarez-Mendez, J.P. Day, P.F. Miller: Selenium status in relatively reduced glutathione peroxidase activity in aspirin-sensitive asthma; Clin Exp Allergy 14(2); 145-148; 1991

90. C. Ezeamuzie. M. Al-Hage: Effects of some anti-asthma drugs on human eosinophile superoxide anions release and degranulation; Int Arch Allergy Immunol 115; 162-168; 1993

91 . R. Crameri, A. Faith, S. Hemmann, R. Jaussi, C. Ismail, G. Menz, K. Blaser: Human cell-mediated autoimmunity in allergy to Aspergillus fumigatus; J Exp Med 184; 265-267; 1995

92 . P. Wang, H. Chen, H. Qin, S. Sankarapandi, M.W. Becher, P.C. Wong, J.L. Zangh: Overexpression of human copper, zinc-superoxide dismutase (SOD-1) prevents postischemic injury; Proc Natl Acad Sci 95; 4556-4560; 1998

93. I. Petyaev, M.J.M. Mitchinson, J. Hunt, P.J. Coussons: Superoxide dismutase antibodies purified from the human arteries and artherosclerotic lesions; Biochem Soc J; 43; 1998

94 . M.B. Mihailovic, D.M. Avramovic, I.B. Jovanovic, O.J. Pesut, D.P. Matic, V.J. Stojanov: Blood plasma selenium levels and GPX-3 activities in patients with arterial hypertension and chronic heart disease; J Environ Pathol Toxicol Oncol 17(3-4); 285-289; 1998

[Seite 95↓]

95 . M.A. Dubick, C.L. Keen, R.A. DiSilvestro, C.D. Eskelson, J. Ireton: Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease; Proc Soc Exp Biol Med 220(1); 39-45; 1999

96 . J. Götz, C.I. va Kan, H.W. Verspaget, I. Biemond, C.B. Lamers, R.A. Veenert: Gastric mucosal superoxide dismutases in Helicobacter pylori infection; Gut 38; 502-505; 1998

97. H.P. Monteiro, E.J. Bechara, D.S. Abdalla: Free radicals involvement in neurological porphyrias and leading to poisoning; Mol Cell Biochem 103(1); 73-83; 1991

98 . A. Seven, Y. Erbil, R. Seven, F. Inci, T. Gulyasar, B. Barutcu, G. Candan: Breast cancer and benign breast disease patients evaluated in relation to oxidative stress; Cancer Biochem Biophys 16(4); 333-345; 1998

99 . T. Mano, R. Shinohara, K. Iwase, M. Kotake, M. Hamada, K. Uchimuro, N. Hayakawa, R. Hayashi, A. Nakai, Y. Ishizuki, A. Nagasaka: Changes in free radicals scavengers and lipid peroxide in thyroid glands of various thyroid disorders; Horm Metab Res 29(7); 351-354; 1997

100 . S. Turi, I. Nemeth, A. Torkos, L. Saghy, I Varga, B. Matkovics, J. Nagy: Oxidative stress and antioxidant defense mechanism in glomerular diseases; Free Radic Biol Med 22(1-2); 161-168; 1997

101 . R. Malmgren, G. Unge, O. Zetterström, H. Theorell, K. De Wahl: Lowered glutathione-peroxidase activity in asthmatic patients with food and aspirin intolerance; DNA Cell Biol 41; 43-45; 1986

102 . A.H. Abou Ghalia, I.M. Fouad: Glutathione and its metabolizing enzymes in patients with different benign and malignant diseases; Clin Biochem 33(8); 657-662; 2000

103 . A. Furuta, D.L. Price, C.A. Pardo, J.C. Troncoso, Z.S. Xu, N. Taniguchi: Localization of superoxide dismutase in Alzheimer´s disease and Down´s syndrome in substantia nigra and hippocampus; Am J Pathol 146; 357-367; 1995

104. D. Price, S.S. Sangram, D.R. Borchelt: Theories of illness and transgenic models; Science 286; 1079-1083; 1998

105 . D. Offen, P.M. Beart, N.S. Cheung, C.J. Pascoe, A. Hochman, S. Gorodin, E.M. Bernard, O. Bernard: Transgenic mice expressing human Bcl-2 are vulnerable to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity; Acad Sci 95; 5789-5794; 1998

106 . C.J. Cunnings, H.Y. Zoghbi: Fourteen and counting: unraveling trinucleotide repeat dieseases; Hum Mol Genet 9 (6); 909-916; 2000

107 . K. Usdin, E. Grabczyk: DNA repeat expansions and human disease; Cell Mol Life Sci 57(6); 914-931; 2000

108 . B.L. Sopher, S.B. Myrick, J.Y. Hong, A.C. Smith, A.R. La Spada: In vivo expansion of trinucleotide repeats yields plasmid and YAC constructs for targeting and transgenesis; Gene 261(2); 383-390; 2000

[Seite 96↓]

109 . A.P. Lieberman, K.H. Fischbeck: Triplet repeat expansion in neuromuscular disease; Muscle & Nerve 23; 843-850; 2000

110 . P. Baldi, S. Brunak, Y. Chauvin, A.G. Pedersen : Structural basis for triplet repeat disorders: a computational analysis; Bioinformatics 15(11); 918-929; 1999

111. V. Meininger: Getting the diagnosis right: beyond El Escorial; J Neurol 246(3); 1999

112 . B.J. Traynor, M.B. Codd, B. Corr, C. Forde, E. Frost, O.M. Hardiman: Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria; Arch Neurol 57; 1171-1176; 2000

113 . H.T. Orr, H.Y. Zoghbi : Polyglutamine tract vs. protein context in SCA1 pathogenesis. In D.C. Rubinsztein und MR. Hayden: Analysis of triplet repeat disorders; BIOS; Oxford; 105-118; 1998

114 . H. Moore, P.W. Greenwell, C.-P. Liu, N. Arnheim, T.D. Peters: Triplet repeats form secondary structures that escape DNA repair in yeast; Proc Natl. Acad. Sci 96(4); 1504-1509; 1999

115 . R.R. Sinden: Biological implications of the DNA structures associated with disease-causing triplet repeats; Am J Hum Genet 64; 346-353; 1999

116. P.D. Chastain, R.R. Sinden : CTG repeats associated with human genetic disease are inherently flexible; J Mol Biol 275; 405-411; 1998

117 . Y.-H. Wang, R. Gellibolian, M. Shimizu, R.D. Wells, J. Griffith: Long CCG triplet repeat blocks exclude nucleosomes – a possible mechanism for the nature of fragile sites in chromosomes; J Mol Biol 263 ; 511-516; 1996

118 . D. Suck: DNA recognition by Dnase I ; J Mol Recognition 7; 65-70; 1994

119 . L. Forsberg, U. de Faire, S.L. Marklund, P.M. Andersson, B. Stegmayr, R. Morgenstern: Phenotype determination of a common Pro-Leu polymorphism i human glutahione peroxidase 1; Blood Cells, Molecules and Diseases; 26(5); 423-426; 2000

120 . T.A. Glauser, M. Titanic-Schefft; C.E. Pippenger: Racial differences in free radical scavenging enzyme activity in children; J Child Neurol; 14(6); 382-387; 1999

121 . E. Beutler, C. West, B. Beutler; Electrophoretic polymorphism of glutathione peroxidase; Ann Hum Genet 38; 163-169; 1974

122 . P. Meera Khan, C. Verma, L.M. Wijnen, S. Jairaj: Red cell glutathione peroxidase (GPX1) variation in Afro-Jamaican, Asiatic-Indian and Dutch population. Is the GPX 1*2 allele of “Thomas” variant an African marker? Hum Genet 66(4); 352-355; 1999